Yuji Naito and Kevin Rocco contributed equally to this work
Tissue Engineering in the Vasculature
Article first published online: 2 DEC 2013
Copyright © 2013 Wiley Periodicals, Inc.
The Anatomical Record
Special Issue: A New Age of Regenerative Medicine: Fusion of Tissue Engineering and Stem Cell Research
Volume 297, Issue 1, pages 83–97, January 2014
How to Cite
Naito, Y., Rocco, K., Kurobe, H., Maxfield, M., Breuer, C. and Shinoka, T. (2014), Tissue Engineering in the Vasculature. Anat Rec, 297: 83–97. doi: 10.1002/ar.22838
- Issue published online: 16 DEC 2013
- Article first published online: 2 DEC 2013
- Manuscript Accepted: 7 NOV 2013
- tissue engineering;
- stem cell;
Tissue engineering holds great promise to address complications and limitations encountered with the use of traditional prosthetic materials, such as thrombogenicity, infection, and future degeneration which represent the major morbidity and mortality after device implant surgery. The general concept of tissue engineering consists of three main components: a scaffold material, a cell type for seeding the scaffold, and biochemical, physio-chemical signaling and remodeling process. This remodeling process is guided by cell signals derived from both seeded cells and host inflammatory cells that infiltrate the scaffold and deposit extracellular matrix, forming the neotissue. Vascular tissue engineering is at the forefront in the translation of this technology to clinical practice, as tissue engineered vascular grafts (TEVGs) have now been successfully implanted in children with congenital heart disease. In this report, we review the history, advances, and state of the art in TEVGs. Anat Rec, 297:83–97. 2014. © 2013 Wiley Periodicals, Inc.